BRAINLIFE.ORG




Current Neuro-Oncology




Volume 2 Number 2
29 February 2000




Home > Publications > Current Neuro-Oncology > Volume 2, Year 2000 > Number 2, 29 February






Bendszus M, Klein R, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L.
Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas.
AJNR Am J Neuroradiol. 2000 Feb;21(2):255-61
. PMID: 10696005. Observational study.




O'Leary G, Bacon CL, Odumeru O, Fagan C, Fitzpatrick T, Gallagher HC, Moriarty DC, Regan CM.
Antiproliferative actions of inhalational anesthetics: comparisons to the valproate teratogen.
Int J Dev Neurosci. 2000 Feb;18(1):39-45. doi: 10.1016/s0736-5748(99)00109-4. PMID: 10708904. Laboratory investigation.




Vlassenko AG, Thiessen B, Beattie BJ, Malkin MG, Blasberg RG.
Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
J Neurooncol. 2000 Feb;46(3):249-59
. doi: 10.1023/a:1006481313747. PMID: 10902856. Interventional study.




Wootton-Gorges SL, Foreman NK, Albano EA, Dertina DM, Nein PK, Shukert B, Cesario KB, Gage S, Rumack CM, Strain JD.
Pattern of recurrence in children with midline posterior fossa malignant neoplasms.
Pediatr Radiol. 2000 Feb;30(2):90-3
. doi: 10.1007/s002470050022. PMID: 10663519. Observational study.




Bouffet E, Raquin M, Doz F, Gentet JC, Rodary C, Demeocq F, Chastagner P, Lutz P, Hartmann O, Kalifa C.
Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas.
Cancer. 2000 Feb 1;88(3):685-92
. doi: 10.1002/(sici)1097-0142(20000201)88:3<685::aid-cncr27>3.0.co;2-k. PMID: 10649264. Interventional study.




Doolittle ND, Miner ME, Hall WA, Siegal T, Jerome E, Osztie E, McAllister LD, Bubalo JS, Kraemer DF, Fortin D, Nixon R, Muldoon LL, Neuwelt EA.
Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.
Cancer. 2000 Feb 1, 2000;88(3):637-47
. doi: 10.1002/(sici)1097-0142(20000201)88:3<637::aid-cncr22>3.0.co;2-y. PMID: 10649259. Observational study.




Graves EE, Nelson SJ, Vigneron DB, Chin C, Verhey L, McDermott M, Larson D, Sneed PK, Chang S, Prados MD, Lamborn K, Dillon WP.
A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas.
Neurosurgery. 2000 Feb 1;46(2):319-26
. doi: 10.1097/00006123-200002000-00011. PMID: 10690720. Observational study.




Hulshof MC, Schimmel EC, Andries Bosch D, González González D.
Hypofractionation in glioblastoma multiforme.
Radiother Oncol. 2000 Feb 1;54(2):143-8. doi: 10.1016/s0167-8140(99)00183-8. PMID: 10699477. Observational study.




Packer RJ, Raffel C, Villablanca JG, Tonn JC, Burdach SE, Burger K, LaFond D, McComb JG, Cogen PH, Vezina G, Kapcala LP.
Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration.
J Neurosurg. 2000 Feb 1;92(2):249-54
. doi: 10.3171/jns.2000.92.2.0249. PMID: 10659011. Interventional study.




Preul MC, Caramanos Z, Villemure JG, Shenouda G, LeBlanc R, Langleben A, Arnold DL.
Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.
Neurosurgery. 2000 Feb 1;46(2):306-18
. doi: 10.1097/00006123-200002000-00009. PMID: 10690719. Observational study.




Reis RM, Könü-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H.
Genetic profile of gliosarcomas.
Am J Pathol. 2000 Feb 1;156(2):425-32
. doi: 10.1016/S0002-9440(10)64746-3. PMID: 10666371. Laboratory investigation.




Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB.
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
J Clin Oncol. 2000 Feb 1;18(3):636-45
. doi: 10.1200/JCO.2000.18.3.636. PMID: 10653879. Laboratory investigation.




Fine HA, Figg WD, Jaeckle K, Wen PY, Kyritsis AP, Loeffler JS, Levin VA, Black PM, Kaplan R, Pluda JM, Yung WK.
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.
J Clin Oncol. 2000 Feb 14;18(4):708-15
. doi: 10.1200/JCO.2000.18.4.708. PMID: 10673511. Interventional study.




Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE, Johnson RS, Jefferson AB, Stokoe D, Giaccia AJ.
Loss of PTEN facilitates HIF-1-mediated gene expression.
Genes Dev. 2000 Feb 15;14(4):391-6
. doi: 10.1101/gad.14.4.391 PMID: 10691731. Laboratory investigation.




Wang C, Zhang J, Liu A, Sun B, Zhao Y.
Surgical treatment of primary midbrain gliomas.
Surg Neurol. 2000 Feb 16;53(1):41-51. doi: 10.1016/s0090-3019(99)00165-2. PMID: 10697232. Observational study.




Gorman AM, Hirt UA, Orrenius S, Ceccatelli S.
Dexamethasone pre-treatment interferes with apoptotic death in glioma cells.
Neuroscience. 2000 Feb 21;96(2):417-25
. doi: 10.1016/s0306-4522(99)00565-5. PMID: 10683582. Laboratory investigation.




Ichiyama T, Okada K, Lipton JM, Matsubara T, Hayashi T, Furukawa S.
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB.
Brain Res. 2000 Feb 28;857(1-2):246-51. doi: 10.1016/s0006-8993(99)02439-7. PMID: 10700573. Laboratory investigation.




Massimino M, Gandola L, Casanova M, Cefalo G, Ferrari A, Luksch R, Riganti G, Lombardi F.
Concomitant chemoradiotherapy for childhood poor-prognosis gliomas.
Med Pediatr Oncol. 2000 Feb 29;34(2):147-50
. doi: 10.1002/(sici)1096-911x(200002)34:2<147::aid-mpo16>3.0.co;2-v. PMID: 10657880. Observational study.